Search Results 531-540 of 16631 for alopecia
Toxicities from previous anti-cancer therapies should have resolved to baseline levels or to Grade 1 or less, (except for alopecia [any grade], Grade less ...
Persistent clinically significant ≥ Grade 2 toxicities from previous chemotherapy (excluding alopecia, nausea, fatigue, anemia, and liver function tests [as ...
This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...
Subjects must not have unresolved clinically significant adverse events Grade ≥ 2 from prior anticancer therapy, except for alopecia or anemia. Subjects ...
Toxicity from previous anticancer therapy must resolve to baseline levels or to Grade 1 or less except for alopecia or peripheral neuropathy. The following ...
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
That team will include your surgeon, a couple of physical medicine and rehabilitation doctors, specifically one who specializes in amputations and another who ...
... alopecia in breast cancer patients. Support Care Cancer. 2023 Nov 22; 31 (12):717. View PubMed; Tawfik B, Dayao ZR, Brown-Glaberman UA, Pankratz VS, Lafky JM ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Research. Mayo Clinic doctors trained in nervous system conditions (neurology) and other areas conduct extensive research in movement disorders.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.